![](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1576849703/news-1172463_1920.jpg/news-1172463_1920.jpg?VersionId=mgpnHbk7Co5__dvZ_o.s5E2ae_oUpz54)
Regulatory tracker: Roche's subcutaneous Ocrevus nabs UK approval
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Monday, July 15 at 9:30 …